Navigation Links
Diamond Vision Announces New and Generous Promotion on its iLASIK in NYC Procedure
Date:9/9/2013

NEW YORK, Sept. 9, 2013 /PRNewswire-iReach/ -- Diamond Vision, a medical facility that offers LASIK in NYC, New Jersey and Connecticut, has just announced a new and very generous promotion on its innovative iLASIK package. For people who are interested in having iLASIK NYC area Diamond Vision will take $2,000 off the regular price of its best refractive surgery package.

(Photo: http://photos.prnewswire.com/prnh/20130909/MN76086)

Dr. Steven Stetson, MD, the Medical Director of Diamond Vision, recently posted a blog on the Diamond Vision website that explains what sets iLASIK apart from traditional LASIK eye surgery.

According to Dr. Stetson, iLASIK involves using exclusively customized wavefront-guided VISX laser technology, which he said is the best the industry has to offer. The iLASIK procedure combines intralase bladeless flap technology, which results in outstanding visual outcomes as well as quicker and more accurate healing. Although some of his competitors also offer this type of LASIK eye surgery in New York, Dr. Stetson said the price that his clinic is offering—which in most cases is around 20 percent less than other locations—makes Diamond Vision the clear choice for the iLASIK procedure.

"With state of the art diagnostics, corneal strength testing that the other centers don't have, and award-winning surgeons, our value speaks for itself," Dr. Stetson wrote, adding that those who would like to read more about the iLASIK procedure can click on a study that is attached to the blog. The study compares wavefront-guided VISX laser outcomes to its closest competitor.

"Remember, iLasik is more than just LASIK, it's a totally customized procedure, specific to you and your eyes alone, combined with the most precise bladeless laser flap technology money can buy."

As Dr. Stetson noted, patients can rest assured that they are getting top-quality care at Diamond Vision. The facility was named by Forbes magazine as one of the Top 10 Lasik Practices in the Nation. In addition, the caring and experienced physicians and staff at Diamond Vision are committed to working with their patients as their vision needs change over time. In addition to iLASIK and LASIK surgery, Diamond Vision also offers cataract surgery and other procedures. As Dr. Stetson wrote, having continuity with a team of medical professionals that already knows their patients and their eyes is priceless.

Anybody who would like to learn more about Diamond Vision is welcome to visit the practice's website; there, they can read more about iLASIK and the other procedures that are offered there, as well as testimonials from patients whose lives and eyesight changed for the better after undergoing a procedure at Diamond Vision.

About Diamond Vision:

Since 2001, Diamond Vision, a team of talented and experienced professionals led for the last 8 years by Dr. Steven Stetson, have offered LASIK and laser eye surgery in New York, New Jersey and Connecticut. Before leading Diamond Vision, Dr. Stetson was chief of the prestigious U.S. Air Force Academy's Laser Eye Surgery center, where he was honored to be the first surgeon in the Air Force to perform Lasik on active duty airmen. For more information, please visit http://www.diamondvision.com

Media Contact: Jayne Caprio, Diamond Vision, (888) 997-4510, diamondvision1234@gmail.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Diamond Vision
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Diamond catalyst shows promise in breaching age-old barrier
2. UCLA researchers find nanodiamonds could improve effectiveness of breast cancer treatment
3. Color in fossil insects, diamonds from the ancient ocean floor and modeling the worlds largest rivers
4. Diamond sheds light on basic building blocks of life
5. Queens Diamond Jubilee Medal for obesity research expert
6. The genome of diamondback moth provides new clues for sustainable pest management
7. Synthetic diamond steps closer to next generation of high performance electrochemical applications
8. Polycrystalline diamond drill bits open up options for geothermal energy
9. Rich or poor in gut bacteria brings new vision for obesity treatment
10. Local Pearle Vision Licensee Adds Second Center In Canton, Ohio
11. BrightFocus Foundation announces $7.2 million in grants for Alzheimers and vision disease research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/28/2017)... 2017 News solutions for biometrics, bag drop ... ... 14 to 16 March, Materna will present its complete end-to-end ... travel is a real benefit for passengers. To accelerate the ... passenger touch point solutions to take passengers through the complete ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
Breaking Biology Technology: